- •We asked if a prescription drug monitoring program (PDMP) changed opioid risks.
- •We matched early PDMP registrants with similarly prescribing nonregistrants.
- •Prescribing risk generally decreased among registrants as well as nonregistrants.
- •Frequent PDMP users showed trends similar to infrequent users.
- •Factors other than PDMP appeared to have greater influence on prescribing trends.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003.Stat Med. 2008; 27: 2037-2049
- Prescription drug monitoring programs are associated with sustained reductions in opioid prescribing by physicians.Health Aff (Millwood). 2016; 35: 1045-1051
- Accuracy of record linkage software in merging dental administrative data sets.J Public Health Dent. 2013; 73: 89-93
- Prescription drug monitoring and dispensing of prescription opioids.Public Health Rep. 2014; 129: 139-147
- Record linkage software in the public domain: a comparison of Link Plus, The Link King, and a ‘basic’ deterministic algorithm.Health Informatics J. 2008; 14: 5-15
- Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysis.Drug Alcohol Depend. 2016; 165: 1-8
- Association between initial opioid prescribing patterns and subsequent long-term use among opioid-naïve patients: A statewide retrospective cohort study.J Gen Intern Med. 2017; 32: 21-27
- Leading a horse to water: Facilitating registration and use of a prescription drug monitoring program.Clin J Pain. 2015; 31: 782-787
- Effect of a centralized prescription network on inappropriate prescriptions for opioid analgesics and benzodiazepines.Can Med Assoc J. 2012; 184: E852-E856
- CDC guideline for prescribing opioids for chronic pain—United States, 2016.JAMA. 2016; 315: 1624-1645
- Two-sided exact tests and matching confidence intervals for discrete data.R Journal. 2010; 2: 53-58
- Evaluating the impact of prescription drug monitoring program implementation: a scoping review.BMC Health Serv Res. 2017; 17: 420
- Can prescription drug monitoring programs help limit opioid abuse?.JAMA. 2011; 306: 2258-2259
- High-risk use by patients prescribed opioids for pain and its role in overdose deaths.JAMA Intern Med. 2014; 174: 796-801
- Effect of a high dosage opioid prior authorization policy on prescription opioid use, misuse, and overdose outcomes.Subst Abus. 2017; (Oct 10; Epub ahead of print)
- How clinicians use prescription drug monitoring programs: A qualitative inquiry.Pain Med. 2014; 15: 1179-1186
- Clinical styles and practice policies: Influence on communication with patients regarding worrisome prescription drug monitoring program data.Pain Med. 2016; 17: 2061-2066
- Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians.J Pain. 2014; 15: 747-755
- Opioid overdose deaths and Florida's crackdown on pill mills.Am J Public Health. 2016; 106: 291-297
- Clinicians' use of prescription drug monitoring programs in clinical practice and decision-making.Pain Med. 2017; 18: 1063-1069
- State legal restrictions and prescription-opioid use among disabled adults.N Engl J Med. 2016; 375: 44-53
- State prescription drug monitoring programs and fatal drug overdoses.Am J Manag Care. 2017; 23: 297-303
- A flood of opioids, a rising tide of deaths.N Engl J Med. 2010; 363: 1981-1985
- Preparing a prescription drug monitoring program data set for research purposes.Pharmacoepidemiol Drug Saf. 2016; 25: 993-997
- Drug Overdose Deaths, Hospitalizations, Abuse & Dependency Among Oregonians.(Available at:)https://public.health.oregon.gov/DiseasesConditions/InjuryFatalityData/Documents/oregon-drug-overdose-report.pdfDate: 2014Date accessed: August 22, 2017
- Do more robust prescription drug monitoring programs reduce prescription opioid overdose?.Addiction. 2016; 112: 1773-1783
- Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates.Health Aff (Millwood). 2016; 35: 1324-1332
- Vital signs: Overdoses of prescription opioid pain relievers, United States, 1999–2008.MMWR Morb Mortal Wkly Rep. 2011; 60: 1487-1492
- Prescription drug monitoring programs and death rates from drug overdose.Pain Med. 2011; 12: 747-754
- A history of being prescribed controlled substances and risk of drug overdose death.Pain Med. 2012; 13: 87-95
- Prescribing practices, knowledge, and use of prescription drug monitoring programs (PDMP) by a national sample of medical toxicologists, 2012.J Med Toxicol. 2012; 8: 341-352
- Increases in drug and opioid overdose deaths—United States, 2000–2014.MMWR Morb Mortal Wkly Rep. 2016; 64: 1378-1382
- Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access.Health Aff (Millwood). 2015; 34: 484-492
- The current utilization and perceptions of prescription drug monitoring programs among emergency medicine providers in Florida.Int J Emerg Med. 2017; 10: 16
Supported by grant number R01 DA031208 from the National Institute on Drug Abuse , and by Grant number UL 1RR024140 , from the National Center for Advancing Translational Sciences .
Richard A. Deyo receives royalties from UpToDate for authoring topics on low back pain and previously received honoraria for board membership at the nonprofit Informed Medical Decisions Foundation. His salary at Oregon Health & Science University is supported in part by an endowment from Kaiser Permanente. He received a financial award from NuVasive, as part of a lifetime achievement award from the International Society for Study of the Lumbar Spine. Dennis McCarty has research awards from the National Institute on Drug Abuse. The remaining authors have no conflicts of interest to declare.